Nephrotic proteinuria as a result of essential hypertension

Kidney and Blood Pressure Research

Volumn 25, Issue 4, 2002, Pages 250-254

  Obialo, Chamberlain I ^a   Hewan Lowe, Karlene ^b   Fulong, Brenda ^c  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

Essential hypertension; Nephrosclerosis; Nephrotic syndrome; Proteinuria

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALBUMIN; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTERIAL PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ELECTRON MICROSCOPY; EOSINOPHIL; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULOPATHY; HUMAN; HYALINE DEGENERATION; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MULTIVARIATE ANALYSIS; NEPHROSCLEROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; REVIEW; STAINING; STANDARD; ARTICLE; BIOPSY; CHRONIC KIDNEY FAILURE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULUS; KIDNEY TUBULE; MIDDLE AGED; PATHOLOGY; RENOVASCULAR HYPERTENSION;

ADULT; AFRICAN AMERICANS; AGED; BIOPSY; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; NEPHROSCLEROSIS; NEPHROTIC SYNDROME; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 1842855147     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066345     Document Type: Review

References (26)

1. Parving HH, Jensen HAE, Mogensen CE, Evrin PE: Increased urinary albuminum excretion rate in benign essential hypertension. Lancet 1974;i:1190-1192.
2. Tomson CR, Peterson K, Heagerty AM: Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens 1991;5:189-192.
3. Kincaid-Smith PS: Renal pathology in hypertension and the effects of treatment. Br J Clin Pharmacol 1982;13:107-115.
4. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int 1997;51:244-252.
5. The National Institutes of Health: US Renal Data System: USRDS 1999. Annual Data Report. Bethesda, NIDDK, 1999.
6. Perneger TV, Whelton P, Klag MJ, Rossiter KA: Diagnosis of hypertensive end-stage renal disease: Effects of patient's race. Am J Epidemiol 1995;141:10-15.
7. Mujais SK, Emmanouel DS, Kasinath BS, Spargo BH: Marked proteinuria in hypertensive nephrosclerosis. Am J Nephrol 1985;5:190-195.
8. Narvarte J, Prive M, Saba SR, Ramirez G: Proteinuria in hypertension. Am J Kidney Dis 1987;10:408-416.
9. Harvey JM, Howie AJ, Lee SJ, Newbold KM, Adu D, Michael J: Renal biopsy findings in hypertensive patients with proteinuria. Lancet 1992;340:1435-1436.
10. Innes A, Johnston PK, Morgan AG, Davison AU, Burden RP: Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Q J Med 1993;86:271-275.
11. Obialo CI, Hewan-Lowe K: Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria. J Natl Med Assoc 1998;90:649-655.
12. Heptinstall RH: Hypertension. I. Essential hypertension; in Heptinstall RH (ed): Pathology of the Kidney. Boston, Little, Brown, 1992, pp 962-971.
13. Buckalew VM, Berg RL, Wang S, Porush JG, Rauch S, Schulman G: Prevalence of hypertension in 1,795 subjects with chronic renal disease: The Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996;28:811-821.
14. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kidney Dis 2000;36:646-661.
15. Koomans HA, Geers AB, Boer P, Roos JC, Mees EJD: A study on the distribution of body fluids after rapid saline expansion in normal subjects and in patients with renal insufficiency: Preferential intravascular deposition in renal failure. Clin Sci (Lond) 1983;64:153-160.
16. Klahr S: Mechanism of progression of chronic renal damage. J Nephrol 1999;12(suppl 2):53-62.
17. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the modification of Diet in Renal Disease Study. Kidney Int 1997;51:1908-1919.
18. Walser M: Progression of chronic renal failure in man. Kidney Int 1990;37:1195-1210.
19. Cameron JS: Proteinuria and progression in human glomerular diseases. Am J Nephrol 1990;10(suppl 1):81-87.
20. Ljungman S: Microalbuminuria in essential hypertension. Am J Hypertens 1990;3:956-960.
21. Ruilope LM, Alcazr JM, Rodicio JL: Renal consequences of arterial hypertension. J Hypertens 1992;10(suppl 7):85-90.
22. Kumar A, Shapiro AP: Proteinuria and nephrotic syndrome induced by renin in patients with renal artery stenosis. Arch Intern Med 1980;140:1631-1634.
23. Docci D, Moscatelli G, Capponcini C, Baldrati L, Feletti C: Nephrotic-range proteinuria in a patient with high renin hypertension: Effect of treatment with an ACE inhibitor. Am J Nephrol 1992;12:387-389.
24. Perera GA: Hypertensive vascular disease: Description and natural history. J Chronic Dis 1995;1:33-42.
25. Keane WF: Proteinuria: Its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000;35(4 suppl 1):97-105.
26. AASK Study Group: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 2001;285:2719-2728.